 double-blind study effect quazolast nasal challenge ragweed antigen Quazolast potent mediator release inhibitor vitro vivo testing placebo-controlled double-blind two-way crossover study safety efficacy Quazolast mg bid placebo subjects ragweed RW allergy season Subjects treatments random sequence washout Subjects days trial serial dilutions mL RW pump spray bottles sprays mL saline control Efficacy evaluation nasal flow rates rhinomanometry sneeze counts nasal itchiness scores weight nasal secretions challenges Quazolast treatment subjects percent decreases nasal flow rate PNU Nasal itchiness scores Quazolast treatment placebo PNU sneeze counts treatment Quazolast placebo results statistical significance significant improvement weight nasal secretions Adverse experiences clinical laboratory results physical examinations unremarkable posttreatment Quazolast superior nasal congestion nasal itchiness ragweed nasal challenge